pLKO.5 shETV5-A Citations (1)

Originally described in: ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition.
Wang B, Krall EB, Aguirre AJ, Kim M, Widlund HR, Doshi MB, Sicinska E, Sulahian R, Goodale A, Cowley GS, Piccioni F, Doench JG, Root DE, Hahn WC Cell Rep. 2017 Feb 7;18(6):1543-1557. doi: 10.1016/j.celrep.2017.01.031. PubMed Journal

---

Articles Citing pLKO.5 shETV5-A

Articles

Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells. Houl JH, Bagheri-Yarmand R, Kunnimalaiyaan M, Miranda Mendez P, Kidd JL, Dadbin A, Ruiz-Jurado A, Parekh PA, Henderson YC, Chari NS, Thennavan A, Powell RT, Stephan CC, Zhao X, Maniakas A, Nurieva R, Busaidy NL, Cabanillas ME, Dadu R, Zafereo M, Wang JR, Lai SY, Hofmann MC. Mol Cancer Ther. 2026 Jan 16:OF1-OF16. doi: 10.1158/1535-7163.MCT-25-0228. PubMed

If you have published an article using this material, please email us at to have your article added to this page.